Do analysts prefer AEMD or BTCY?

Aethlon Medical currently has a consensus price target of $1.50, suggesting a potential downside of 75.21%. Given Aethlon Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Aethlon Medical is more favorable than Biotricity. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend BTCY or ICCM?

IceCure Medical has a consensus target price of $30.00, indicating a potential upside of 2,627.27%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Biotricity. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 IceCure Medical 2 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is BTCY or ICCM more profitable?

Biotricity has a net margin of -80.42% compared to IceCure Medical's net margin of -427.67%. Biotricity's return on equity of 0.00% beat IceCure Medical's return on equity. Company Net Margins Return on Equity Return on Assets Biotricity -80.42% N/A -188.47% IceCure Medical -427.67% -174.26% -112.58%

Do analysts prefer ZYXI or BTCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, ZYXI or BTCY?

Zynex has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A Biotricity $12.06M 0.09 -$14.09M -$0.14 N/A

Is ZYXI or BTCY more profitable?

Zynex has a net margin of -68.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Biotricity -80.42% N/A -188.47%

Do analysts recommend BTCY or BJDX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bluejay Diagnostics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer BTCY or AMIX?

Autonomix Medical has a consensus target price of $42.00, indicating a potential upside of 1,250.48%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Biotricity. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Biotricity (BTCY) Competitors

$0.05 0.00 (-3.49%)

As of 10/9/2026 03:55 PM Eastern

Compare

BTCY vs. AEMD, ICCM, ZYXI, BJDX, and AMIX

Should you buy Biotricity stock or one of its competitors? Biotricity's main competitors and comparable companies include Aethlon Medical (AEMD), IceCure Medical (ICCM), Zynex (ZYXI), Bluejay Diagnostics (BJDX), and Autonomix Medical (AMIX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Biotricity compare to Aethlon Medical?

Aethlon Medical (NASDAQ:AEMD) and Biotricity (NASDAQ:BTCY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 0.6% of Aethlon Medical shares are held by company insiders. Comparatively, 1.6% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aethlon Medical has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market. Comparatively, Biotricity has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market.

Aethlon Medical currently has a consensus price target of $1.50, suggesting a potential downside of 75.21%. Given Aethlon Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Aethlon Medical is more favorable than Biotricity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Aethlon Medical had 1 more articles in the media than Biotricity. MarketBeat recorded 1 mentions for Aethlon Medical and 0 mentions for Biotricity. Aethlon Medical's average media sentiment score of 0.75 beat Biotricity's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Aethlon Medical	Positive
Biotricity	Neutral

Aethlon Medical has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
Biotricity	$12.06M	0.09	-$14.09M	-$0.14	N/A

Aethlon Medical has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
Biotricity	-80.42%	N/A	-188.47%

Summary

Aethlon Medical beats Biotricity on 7 of the 13 factors compared between the two stocks.

How does Biotricity compare to IceCure Medical?

Biotricity (NASDAQ:BTCY) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Biotricity has higher revenue and earnings than IceCure Medical. Biotricity is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.09	-$14.09M	-$0.14	N/A
IceCure Medical	$3.95M	0.95	-$15.06M	-$8.52	N/A

In the previous week, IceCure Medical had 5 more articles in the media than Biotricity. MarketBeat recorded 5 mentions for IceCure Medical and 0 mentions for Biotricity. Biotricity's average media sentiment score of 0.00 equaled IceCure Medical'saverage media sentiment score.

Company	Overall Sentiment
Biotricity	Neutral
IceCure Medical	Neutral

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 1.6% of Biotricity shares are owned by company insiders. Comparatively, 2.4% of IceCure Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Biotricity has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

IceCure Medical has a consensus target price of $30.00, indicating a potential upside of 2,627.27%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Biotricity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
IceCure Medical	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Biotricity has a net margin of -80.42% compared to IceCure Medical's net margin of -427.67%. Biotricity's return on equity of 0.00% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
IceCure Medical	-427.67%	-174.26%	-112.58%

Summary

Biotricity beats IceCure Medical on 8 of the 15 factors compared between the two stocks.

How does Biotricity compare to Zynex?

Zynex (NASDAQ:ZYXI) and Biotricity (NASDAQ:BTCY) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

Zynex has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Biotricity	$12.06M	0.09	-$14.09M	-$0.14	N/A

Zynex has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Biotricity has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

Zynex has a net margin of -68.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Biotricity	-80.42%	N/A	-188.47%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Zynex's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.

Company	Overall Sentiment
Zynex	Neutral
Biotricity	Neutral

29.7% of Zynex shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 49.3% of Zynex shares are held by insiders. Comparatively, 1.6% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Zynex beats Biotricity on 7 of the 12 factors compared between the two stocks.

How does Biotricity compare to Bluejay Diagnostics?

Biotricity (NASDAQ:BTCY) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

3.9% of Biotricity shares are held by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are held by institutional investors. 1.6% of Biotricity shares are held by insiders. Comparatively, 6.1% of Bluejay Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Bluejay Diagnostics has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Bluejay Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Bluejay Diagnostics	N/A	-125.00%	-99.79%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bluejay Diagnostics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Bluejay Diagnostics had 1 more articles in the media than Biotricity. MarketBeat recorded 1 mentions for Bluejay Diagnostics and 0 mentions for Biotricity. Biotricity's average media sentiment score of 0.00 equaled Bluejay Diagnostics'average media sentiment score.

Company	Overall Sentiment
Biotricity	Neutral
Bluejay Diagnostics	Neutral

Biotricity has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market. Comparatively, Bluejay Diagnostics has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

Bluejay Diagnostics has lower revenue, but higher earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.09	-$14.09M	-$0.14	N/A
Bluejay Diagnostics	N/A	N/A	-$6.85M	-$7.11	N/A

Summary

Bluejay Diagnostics beats Biotricity on 7 of the 12 factors compared between the two stocks.

How does Biotricity compare to Autonomix Medical?

Biotricity (NASDAQ:BTCY) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 1.6% of Biotricity shares are owned by company insiders. Comparatively, 5.5% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Autonomix Medical has a consensus target price of $42.00, indicating a potential upside of 1,250.48%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Biotricity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Biotricity has higher revenue and earnings than Autonomix Medical. Biotricity is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.09	-$14.09M	-$0.14	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

In the previous week, Autonomix Medical had 3 more articles in the media than Biotricity. MarketBeat recorded 3 mentions for Autonomix Medical and 0 mentions for Biotricity. Biotricity's average media sentiment score of 0.00 equaled Autonomix Medical'saverage media sentiment score.

Company	Overall Sentiment
Biotricity	Neutral
Autonomix Medical	Neutral

Autonomix Medical has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Autonomix Medical	N/A	-267.73%	-216.75%

Biotricity has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -0.96, suggesting that its stock price is 196% less volatile than the broader market.

Summary

Biotricity and Autonomix Medical tied by winning 7 of the 14 factors compared between the two stocks.

Get Biotricity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BTCY vs. The Competition

Export

Metric	Biotricity	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.09M	$5.43B	$7.16B	$13.21B
Dividend Yield	N/A	1.77%	2.53%	16.37%
P/E Ratio	-0.05	25.57	275.30	26.16
Price / Sales	0.09	83.34	635.97	107.53
Price / Cash	N/A	31.87	76.38	53.09
Price / Book	-0.04	5.95	11.22	6.33
Net Income	-$14.09M	$146.18M	$3.50B	$382.15M
7 Day Performance	N/A	-0.28%	-0.89%	-1.40%
1 Month Performance	N/A	-1.88%	-4.42%	-3.47%
1 Year Performance	N/A	5.45%	7.03%	1.18%

Biotricity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BTCY Biotricity	N/A	$0.05 -3.5%	N/A	-92.2%	$1.09M	$12.06M	N/A	46
AEMD Aethlon Medical	1.0475 of 5 stars	$6.01 -1.0%	$1.50 -75.0%	-83.6%	$4.32M	N/A	N/A	9
ICCM IceCure Medical	3.28 of 5 stars	$1.13 -1.7%	$30.00 +2,554.9%	-96.2%	$3.94M	$3.38M	N/A	68	Short Interest Decrease
ZYXI Zynex	N/A	$0.13 flat	N/A	N/A	$3.80M	$108.20M	N/A	770
BJDX Bluejay Diagnostics	0.4824 of 5 stars	$0.82 +0.7%	N/A	-93.7%	$3.62M	N/A	N/A	6

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BTCY) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biotricity (BTCY) Competitors

BTCY vs. AEMD, ICCM, ZYXI, BJDX, and AMIX

How does Biotricity compare to Aethlon Medical?

Summary

How does Biotricity compare to IceCure Medical?

Summary

How does Biotricity compare to Zynex?

Summary

How does Biotricity compare to Bluejay Diagnostics?

Summary

How does Biotricity compare to Autonomix Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY vs. The Competition

Biotricity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biotricity (BTCY) Competitors

BTCY vs. AEMD, ICCM, ZYXI, BJDX, and AMIX

How does Biotricity compare to Aethlon Medical?

Do institutionals & insiders believe in AEMD or BTCY?

Which has more volatility and risk, AEMD or BTCY?

Do analysts prefer AEMD or BTCY?

Does the media refer more to AEMD or BTCY?

Which has preferable earnings & valuation, AEMD or BTCY?

Is AEMD or BTCY more profitable?

Summary

How does Biotricity compare to IceCure Medical?

Which has preferable earnings and valuation, BTCY or ICCM?

Does the media prefer BTCY or ICCM?

Do institutionals & insiders have more ownership in BTCY or ICCM?

Which has more volatility & risk, BTCY or ICCM?

Do analysts recommend BTCY or ICCM?

Is BTCY or ICCM more profitable?

Summary

How does Biotricity compare to Zynex?

Which has stronger earnings and valuation, ZYXI or BTCY?

Which has more risk and volatility, ZYXI or BTCY?

Is ZYXI or BTCY more profitable?

Do analysts prefer ZYXI or BTCY?

Does the media favor ZYXI or BTCY?

Do insiders and institutionals hold more shares of ZYXI or BTCY?

Summary

How does Biotricity compare to Bluejay Diagnostics?

Do insiders & institutionals have more ownership in BTCY or BJDX?

Is BTCY or BJDX more profitable?

Do analysts recommend BTCY or BJDX?

Does the media prefer BTCY or BJDX?

Which has more volatility & risk, BTCY or BJDX?

Which has better earnings and valuation, BTCY or BJDX?

Summary

How does Biotricity compare to Autonomix Medical?

Do institutionals and insiders believe in BTCY or AMIX?

Do analysts prefer BTCY or AMIX?

Which has higher earnings & valuation, BTCY or AMIX?

Does the media refer more to BTCY or AMIX?

Is BTCY or AMIX more profitable?

Which has more volatility & risk, BTCY or AMIX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY vs. The Competition

Biotricity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools